SCHEMBL25344261

SCHEMBL25344261

Cc1n[nH]cc1-c1nc(N)c(Br)cc1C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.31
MBOAT4 Q96T53 1/20 0.31
MPL P40238 1/20 0.31
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25344718 0.76 KDM4E (0.37) MPL
SCHEMBL25345643 0.72 TRPA1 (0.35)
SCHEMBL21412576 0.69 PDE3B (0.38) AR
SCHEMBL25345237 0.68 TRPA1 (0.36)
SCHEMBL15538013 0.68 MBOAT4 (0.40) MBOAT4MPLAR
SCHEMBL25203566 0.68 AURKA (0.39)
SCHEMBL19813042 0.67 HTT (0.42)
SCHEMBL24500129 0.65 AR (0.34) MBOAT4AR
SCHEMBL26025616 0.65 AXL (0.40)
SCHEMBL2198261 0.65 HSD11B1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4476204-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS Theras, Inc. (US) 2024-12-18 EP disclosed
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed